Free Trial
Notice: This company recently went public with an IPO on the week of January 13th 2025. They issued 20,000,000 shares at $10.00 per share. We will continue to update data for DMAAU as it becomes available.
NASDAQ:DMAAU

Drugs Made in America Acquisition (DMAAU) Stock Price, News & Analysis

About Drugs Made in America Acquisition Stock (NASDAQ:DMAAU)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we may pursue a business combination target in any business, industry or geographical location, we intend to focus our search for businesses in the pharmaceutical industry. Our executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301 and our telephone number is (954) 870-3099.

Receive DMAAU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Drugs Made in America Acquisition and its competitors with MarketBeat's FREE daily newsletter.

DMAAU Stock News Headlines

Drugs Made In America Acquisition Corporation Cons of 1 Shs + 1-10 Rt
See More Headlines

DMAAU Stock Analysis - Frequently Asked Questions

Drugs Made in America Acquisition (DMAAU) raised $200 million in an IPO on the week of January 13th 2025. The company issued 20,000,000 shares at $10.00 per share. Clear Street served as the underwriter for the IPO.

Shares of DMAAU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Industry
Investment Offices
Sub-Industry
Trading
Current Symbol
NASDAQ:DMAAU
Web
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
N/A
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:DMAAU) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners